Skip to contentP
Pure Bioscience, Inc.
P
PUREPure Bioscience, Inc. Q4 2016 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$524.00K$524.00Kderived+127.8% vs Q4 2015 Net Income-$679.00K-$679.00KderivedN/M vs Q4 2015 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pure Bioscience, Inc. · CIK 1006028 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$1,447,000N/M Operating Cash Flowderived-$1,272,000N/M Free Cash Flowderived-$1,325,000N/M Margins · derivedOperating margin-276.1%+538.6 pt vs Q4 2015
Net margin-129.6%+681.7 pt vs Q4 2015
ended Jul 31, 2016 · filed Oct 27, 2016 · 88 d after period end